Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Austria Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20074
20081
20093
20101
20131
20141
20151
20162
20172
20202
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck KGaA, Darmstadt, Germany3
AIO-Studien-gGmbH2
Amgen2
Novartis Pharmaceuticals2
Philogen S.p.A.2
Abscint NV/SA1
Association of Research on the Biology of Liver Tumors1
AstraZeneca1
Bayer1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis25
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms3
Neoplasms3
Carcinoma, Transitional Cell2
Lung Neoplasms2
Melanoma2
Recurrence2
Acrocephalosyndactylia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.